1 Introduction 6

• 1.1 Industry Definition and Research Scope 6
  • 1.1.1 Industry Definition 6
  • 1.1.2 Research Scope 7
• 1.2 Research Methodology 9
  • 1.2.1 Overview of Market Research Methodology 9
  • 1.2.2 Market Assumption 10
  • 1.2.3 Secondary Data 10
  • 1.2.4 Primary Data 10
  • 1.2.5 Data Filtration and Model Design 11
  • 1.2.6 Market Size/Share Estimation 12
  • 1.2.7 Research Limitations 13
• 1.3 Executive Summary 14

2 Market Overview and Dynamics 16

• 2.1 Market Size and Forecast 16
• 2.2 Major Growth Drivers 17
• 2.3 Market Restraints and Challenges 20
• 2.4 Emerging Opportunities and Market Trends 23
• 2.5 Porter’s Fiver Forces Analysis 26

3 Segmentation of Asia-Pacific Market by Product Type 30

• 3.1 Market Overview by Product Type 30
• 3.2 Fixation Devices 33
  • 3.2.1 Tack 34
  • 3.2.2 Staple 35
  • 3.2.3 Suture 36
  • 3.2.3 Glue 37
• 3.3 Consumables (Mesh) 38
  • 3.3.1 Biological Mesh 39
  • 3.3.2 Synthetic Mesh 40

4 Segmentation of Asia-Pacific Market by Surgery Type 42

• 4.1 Market Overview by Surgery Type 42
• 4.2 Open-Tension Free Repair 44
• 4.3 Laparoscopic Tension Free Repair 45
• 4.4 Tension Repair 46
• 4.5 Robotic-Assisted Hernia Repair 47

5 Segmentation of Asia-Pacific Market by Hernia Type 48

• 5.1 Market Overview by Hernia Type 48
• 5.2 Umbilical 51
• 5.3 Incisional 52
• 5.4 Femoral 53
• 5.5 Inguinal 54
• 5.6 Paraumbilical 55
• 5.7 Epigastric 56
• 5.8 Other Hernia Types 57

6 Segmentation of Asia-Pacific Market by End-user 58

• 6.1 Market Overview by End-user 58
• 6.2 Ambulatory Surgical Centers 60
• 6.3 Clinics 61
• 6.4 Hospitals 62

7 Asia-Pacific Market 2019-2026 by Country 63

• 7.1 Overview of Asia-Pacific Market 63
• 7.2 Japan 66
• 7.3 China 69
• 7.4 Australia 71
• 7.5 India 73
• 7.6 South Korea 75
• 7.7 Rest of APAC Region 77

8 Competitive Landscape 79

• 8.1 Overview of Key Vendors 79
• 8.2 New Product Launch, Partnership, Investment, and M&A 83
• 8.3 Company Profiles 85

Becton, Dickinson And Company 85

B. Braun Melsungen AG 87

Baxter International, Inc. 88

C.R. Bard, Inc. 89

Cook Medical, Inc. 90

Cousin Biotech 91

Duomed Group 92

Ethicon, Inc. (Johnson & Johnson) 93

Getinge AB 94

Herniamesh S.r.l. 95

Integra Lifesciences Holding Corp. 96

LifeCell Corp. (Allergan) 97

MAQUET Holding B.V. & Co. KG. 98

Medline Industries, Inc. 99

Medtronic PLC. 100

Olympus Corp. 101

The Cooper Companies, Inc. 102

TransEasy Medical Tech. Co., Ltd. 103

Via Surgical Ltd. 104

W. L. Gore & Associates, Inc. 105

9 Investing in Asia-Pacific Market: Risk Assessment and Management 106

• 9.1 Risk Evaluation of Asia-Pacific Market 106
• 9.2 Critical Success Factors (CSFs) 109

Related Reports and Products 112

Asia Pacific hernia repair market will grow by 6.1% over 2020-2026 with a total addressable market cap of $8.7 billion in the fast-growing region.
Highlighted with 36 tables and 46 figures, this 112-page report “Asia Pacific Hernia Repair Market 2020-2026 by Product Type, Surgery Type, Hernia Type, End-user, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific hernia repair market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with estimates and forecast covering 2020-2026. (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify Asia Pacific hernia repair market in every aspect of the classification from perspectives of Product Type, Surgery Type, Hernia Type, End-user, and Country.
Based on product type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Fixation Devices (further segmented into Tack (split into Absorbable Tack and Non-absorbable Tack), Staple, Suture, Glue)
• Consumables (Mesh) (further segmented into Biological Mesh and Synthetic Mesh (further split into Absorbable Mesh and Non-Absorbable Mesh; Flat Mesh and 3D Mesh))
Based on surgery type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Open-Tension Free Repair
• Laparoscopic Tension Free Repair
• Tension Repair
• Robotic-Assisted Hernia Repair
Based on hernia type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Umbilical
• Incisional
• Femoral
• Inguinal
• Paraumbilical
• Epigastric
• Others
Based on end user, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.
• Ambulatory Surgical Centers
• Clinics
• Hospitals
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
For each of the aforementioned countries, market analysis and revenue data are available for 2019-2026. The breakdown of major national markets by Product Type, Surgery Type, and End-user over the study years (2019-2026) is included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia Pacific hernia repair market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players:
Becton, Dickinson And Company
B. Braun Melsungen AG
Baxter International, Inc.
C.R. Bard, Inc.
Cook Medical, Inc.
Cousin Biotech
Duomed Group
Ethicon, Inc. (Johnson & Johnson)
Getinge AB
Herniamesh S.r.l.
Integra Lifesciences Holding Corp.
LifeCell Corp. (Allergan)
MAQUET Holding B.V. & Co. KG.
Medline Industries, Inc.
Medtronic PLC.
Olympus Corp.
The Cooper Companies, Inc.
TransEasy Medical Tech. Co., Ltd.
Via Surgical Ltd.
W. L. Gore & Associates, Inc.
(Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)